199 related articles for article (PubMed ID: 37701941)
1. Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov G; Smolnikov E; Litovkina A; Jiang T; Shatilov A; Tulaeva I; Tulaev M; Karaulov A; Poroshina A; Zhernov Y; Focke-Tejkl M; Weber M; Akinfenwa O; Elisyutina O; Andreev S; Shilovskiy I; Shershakova N; Smirnov V; Fedenko E; Lepeshkova TS; Beltyukov EC; Naumova VV; Kundi M; Khaitov M; Wiedermann U; Valenta R; Campana R
Allergy; 2023 Dec; 78(12):3136-3153. PubMed ID: 37701941
[TBL] [Abstract][Full Text] [Related]
2. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
3. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
4. Isotype-specific binding patterns of serum antibodies to multiple conformational epitopes of Bet v 1.
Schmalz S; Mayr V; Shosherova A; Gepp B; Ackerbauer D; Sturm G; Bohle B; Breiteneder H; Radauer C
J Allergy Clin Immunol; 2022 May; 149(5):1786-1794.e12. PubMed ID: 34740603
[TBL] [Abstract][Full Text] [Related]
5. Recombinant PreS-fusion protein vaccine for birch pollen and apple allergy.
Khaitov M; Shilovskiy I; Valenta R; Weber M; Korneev A; Tulaeva I; Gattinger P; van Hage M; Hofer G; Konradsen JR; Keller W; Akinfenwa O; Poroshina A; Ilina N; Fedenko E; Elisyutina O; Litovkina A; Smolnikov E; Nikonova A; Rybalkin S; Aldobaev V; Smirnov V; Shershakova N; Petukhova O; Kudlay D; Shatilov A; Timofeeva A; Campana R; Udin S; Skvortsova V
Allergy; 2024 Apr; 79(4):1001-1017. PubMed ID: 37855043
[TBL] [Abstract][Full Text] [Related]
6. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
7. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
[TBL] [Abstract][Full Text] [Related]
8.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
9. Expression of a human IgG4 antibody, BAB2, with specificity for the major Birch pollen allergen, Bet v 1 in Escherichia coli: recombinant BAB2 Fabs enhance the allergic reaction.
Eibensteiner P; Denépoux S; Steinberger P; Kraft D; Visco V; Banchereau J; Lebecque S; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):190-2. PubMed ID: 10224374
[TBL] [Abstract][Full Text] [Related]
10. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
11. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
13. Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v 1.
Zettl I; Ivanova T; Strobl MR; Weichwald C; Goryainova O; Khan E; Rutovskaya MV; Focke-Tejkl M; Drescher A; Bohle B; Flicker S; Tillib SV
Allergy; 2022 Jun; 77(6):1751-1760. PubMed ID: 34837242
[TBL] [Abstract][Full Text] [Related]
14. IgE and allergen-specific immunotherapy-induced IgG
Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
[TBL] [Abstract][Full Text] [Related]
15. IgE, IgG4 and IgA specific to Bet v 1-related food allergens do not predict oral allergy syndrome.
Guhsl EE; Hofstetter G; Lengger N; Hemmer W; Ebner C; Fröschl R; Bublin M; Lupinek C; Breiteneder H; Radauer C
Allergy; 2015 Jan; 70(1):59-66. PubMed ID: 25327982
[TBL] [Abstract][Full Text] [Related]
16. Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.
Seutter von Loetzen C; Reuter A; Spiric J; Schulenborg T; Bellinghausen I; Völker E; Vogel L; Rösch P; Schiller D
Clin Exp Allergy; 2019 May; 49(5):712-723. PubMed ID: 30706562
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
[TBL] [Abstract][Full Text] [Related]
18. Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.
Pree I; Reisinger J; Focke M; Vrtala S; Pauli G; van Hage M; Cromwell O; Gadermaier E; Egger C; Reider N; Horak F; Valenta R; Niederberger V
J Immunol; 2007 Oct; 179(8):5309-16. PubMed ID: 17911617
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments.
Gadermaier E; Marth K; Lupinek C; Campana R; Hofer G; Blatt K; Smiljkovic D; Roder U; Focke-Tejkl M; Vrtala S; Keller W; Valent P; Valenta R; Flicker S
Allergy; 2018 Jul; 73(7):1425-1435. PubMed ID: 29315611
[TBL] [Abstract][Full Text] [Related]
20. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
